Related Experiment Video
Updated: May 26, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Ecstasy-induced thyrotoxic periodic paralysis
1Prince Phillip Hospital, Diabetes and Endocrinology, Dafan, Llanelli, Wales, SA14 8QF, UK.
BMJ Case Reports
|December 23, 2011
Summary
Recreational ecstasy use can trigger thyrotoxic periodic paralysis (TPP) attacks in susceptible individuals. This case study highlights ecstasy as a novel precipitant of TPP, emphasizing the need for awareness among clinicians and patients.
Area of Science:
- Endocrinology
- Toxicology
- Emergency Medicine
Background:
- Thyrotoxic periodic paralysis (TPP) is a rare neuromuscular disorder characterized by episodic hypokalemic muscle weakness.
- TPP is often precipitated by factors like stress, diet, and certain medications in individuals with hyperthyroidism.
Purpose of the Study:
- To report the first documented case of recreational ecstasy use as a precipitant of thyrotoxic periodic paralysis (TPP).
Main Methods:
- Case report of a 21-year-old male with recurrent TPP admissions.
- Review of patient's medical history, treatment compliance, and recreational drug use.
- Correlation of TPP episodes with reported ecstasy consumption.
Main Results:
- The patient experienced recurrent TPP episodes despite carbimazole treatment.
- Each admission was preceded by recreational ecstasy use.
- Ecstasy use was identified as a consistent trigger for TPP in this patient.
Conclusions:
- Recreational ecstasy use can precipitate thyrotoxic periodic paralysis (TPP).
- This finding expands the known triggers for TPP and highlights the importance of detailed substance use history in managing hyperthyroid patients.
- Clinicians should consider recreational drug use, including ecstasy, in the differential diagnosis for TPP exacerbations.
Related Concept Videos
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...